Fibrinolytically active polypeptide

Details for Australian Patent Application No. 2004200776 (hide)

Owner Amgen Inc.

Inventors Boone, Thomas Charles; Mann, Michael Benjamin; Li, Huimin

Agent Shelston IP

Pub. Number AU-B-2004200776

Parent 767827

Filing date 27 February 2004

Wipo publication date 25 March 2004

Acceptance publication date 13 July 2006

International Classifications

C12N 15/57 (2006.01) Mutation or genetic engineering - acting on peptide bonds (3.4)

C07K 16/40 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 9/64 (2006.01) Enzymes, e.g. ligases (6.) - derived from animal tissue, e.g. rennin

Event Publications

11 March 2004 Complete Application Filed

25 March 2004 Application Open to Public Inspection

  Published as AU-B-2004200776

13 July 2006 Application Accepted

  Published as AU-B-2004200776

30 November 2006 Standard Patent Sealed

23 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004200777-Gaming machine

2004200775-Gutter block